Skip to main content
Erschienen in: Journal of Neurology 7/2012

01.07.2012 | Original Communication

Screening for balance disorders in mildly affected multiple sclerosis patients

verfasst von: Malou H. J. Fanchamps, Henrik Gensicke, Jens Kuhle, Ludwig Kappos, John H. J. Allum, Özgür Yaldizli

Erschienen in: Journal of Neurology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis (MS) patients often complain about balance problems when Romberg’s test and tandem gait are normal. The aim of the study was to determine if measures of trunk sway taken during a battery of stance and gait tasks could be used to detect subclinical balance disorders. We recorded trunk angular sway in the pitch and roll directions from 20 MS patients (EDSS 1.4 ± 0.5) and 20 age- and gender-matched healthy controls (HCs), during 12 stance and gait tasks. We filmed 22 subjects simultaneously. Two neurologists assessed the videos, deciding whether task performance was pathological. Sway measures were significantly different between patients and HCs in eight out of 12 balance tasks. The most significant differences between MS patients and HCs were pitch angle range standing on one leg with eyes open on a firm surface (mean 3.13° vs. 2.09°, p = 0.005), and on a foam support surface (mean 6.24° vs. 2.96°, p = 0.006), pitch velocity range walking 8 m with eyes closed (mean 75.5 vs. 50.2°/s, p < 0.001) and pitch velocity range walking 3 m on heels (mean 85.37 vs. 60.9°/s, p = 0.002). Multivariate analysis revealed a model with three tasks which detected balance disorders in 84% of the MS patients and 90% of the HCs correctly. The neurologists achieved accuracies of 30% for the MS patients and 82% for the HCs. Using trunk sway measures during stance and gait tasks is a sensitive screening method for balance problems in MS patients, and is more accurate than assessment by trained neurologists.
Literatur
1.
Zurück zum Zitat Corradini ML, Fioretti S, Leo T, Piperno R (1997) Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study. IEEE Trans Biomed Eng 44:1029–1038PubMedCrossRef Corradini ML, Fioretti S, Leo T, Piperno R (1997) Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study. IEEE Trans Biomed Eng 44:1029–1038PubMedCrossRef
2.
Zurück zum Zitat Karst GM, Venema DM, Roehrs TG, Tyler AE (2005) Center of pressure measures during standing tasks in minimally impaired persons with multiple sclerosis. J Neurol Phys Ther 29:170–180PubMed Karst GM, Venema DM, Roehrs TG, Tyler AE (2005) Center of pressure measures during standing tasks in minimally impaired persons with multiple sclerosis. J Neurol Phys Ther 29:170–180PubMed
3.
Zurück zum Zitat Gensicke H, Corporaal S, Kappos L, Allum J, Yaldizli Ö (2011) Correlations of balance instability and disability in multiple sclerosis patients [abstract]. J Neurol 258:P92 Gensicke H, Corporaal S, Kappos L, Allum J, Yaldizli Ö (2011) Correlations of balance instability and disability in multiple sclerosis patients [abstract]. J Neurol 258:P92
4.
Zurück zum Zitat Soyuer F, Mirza M, Erkorkmaz U (2006) Balance performance in three forms of multiple sclerosis. Neurol Res 28:555–562PubMedCrossRef Soyuer F, Mirza M, Erkorkmaz U (2006) Balance performance in three forms of multiple sclerosis. Neurol Res 28:555–562PubMedCrossRef
5.
Zurück zum Zitat Cattaneo D, Cardini R (2001) Computerized system to improve voluntary control of balance in neurological patients. Cyberpsychol Behav 4:687–694PubMedCrossRef Cattaneo D, Cardini R (2001) Computerized system to improve voluntary control of balance in neurological patients. Cyberpsychol Behav 4:687–694PubMedCrossRef
6.
Zurück zum Zitat Cakt BD, Nacir B, Genc H, Saracoglu M, Karagoz A, Erdem HR et al (2010) Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study. Am J Phys Med Rehabil 89:446–457PubMedCrossRef Cakt BD, Nacir B, Genc H, Saracoglu M, Karagoz A, Erdem HR et al (2010) Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study. Am J Phys Med Rehabil 89:446–457PubMedCrossRef
7.
Zurück zum Zitat Missaoui B, Thoumie P (2009) How far do patients with sensory ataxia benefit from so-called “proprioceptive rehabilitation”? Neurophysiol Clin 39:229–233PubMedCrossRef Missaoui B, Thoumie P (2009) How far do patients with sensory ataxia benefit from so-called “proprioceptive rehabilitation”? Neurophysiol Clin 39:229–233PubMedCrossRef
8.
Zurück zum Zitat Widener GL, Allen DD, Gibson-Horn C (2009) Randomized clinical trial of balance-based torso weighting for improving upright mobility in people with multiple sclerosis. Neurorehabil Neural Repair 23:784–791PubMedCrossRef Widener GL, Allen DD, Gibson-Horn C (2009) Randomized clinical trial of balance-based torso weighting for improving upright mobility in people with multiple sclerosis. Neurorehabil Neural Repair 23:784–791PubMedCrossRef
9.
Zurück zum Zitat Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846PubMedCrossRef Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846PubMedCrossRef
10.
Zurück zum Zitat Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427PubMedCrossRef Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427PubMedCrossRef
11.
Zurück zum Zitat Cattaneo D, Jonsdottir J, Zocchi M, Regola A (2007) Effects of balance exercises on people with multiple sclerosis: a pilot study. Clin Rehabil 21:771–781PubMedCrossRef Cattaneo D, Jonsdottir J, Zocchi M, Regola A (2007) Effects of balance exercises on people with multiple sclerosis: a pilot study. Clin Rehabil 21:771–781PubMedCrossRef
12.
Zurück zum Zitat Cameron MH, Horak FB, Herndon RR, Bourdette D (2008) Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction. Somatosens Mot Res 25:113–122PubMedCrossRef Cameron MH, Horak FB, Herndon RR, Bourdette D (2008) Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction. Somatosens Mot Res 25:113–122PubMedCrossRef
13.
Zurück zum Zitat Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E et al (2006) Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 12:620–628PubMedCrossRef Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E et al (2006) Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 12:620–628PubMedCrossRef
14.
Zurück zum Zitat Findling O, Sellner J, Meier N, Allum JH, Vibert D, Lienert C et al (2011) Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment. Exp Brain Res 213:363–370PubMedCrossRef Findling O, Sellner J, Meier N, Allum JH, Vibert D, Lienert C et al (2011) Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment. Exp Brain Res 213:363–370PubMedCrossRef
15.
Zurück zum Zitat Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15:918–927PubMedCrossRef Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15:918–927PubMedCrossRef
16.
Zurück zum Zitat Hegeman J, Shapkova EY, Honegger F, Allum JH (2007) Effect of age and height on trunk sway during stance and gait. J Vestib Res 17:75–87PubMed Hegeman J, Shapkova EY, Honegger F, Allum JH (2007) Effect of age and height on trunk sway during stance and gait. J Vestib Res 17:75–87PubMed
17.
Zurück zum Zitat (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352:1498–504 (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352:1498–504
18.
Zurück zum Zitat IFNB Multiple Scleriosis Study Group (2001) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article]. Neurology 57:S3–S9 IFNB Multiple Scleriosis Study Group (2001) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article]. Neurology 57:S3–S9
19.
Zurück zum Zitat Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM et al (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The multiple sclerosis collaborative research group (MSCRG). Ann Neurol 39:285–294PubMedCrossRef Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM et al (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The multiple sclerosis collaborative research group (MSCRG). Ann Neurol 39:285–294PubMedCrossRef
20.
Zurück zum Zitat Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The copolymer 1 multiple sclerosis study group. Neurology 45:1268–1276PubMedCrossRef Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The copolymer 1 multiple sclerosis study group. Neurology 45:1268–1276PubMedCrossRef
21.
Zurück zum Zitat Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899–910PubMedCrossRef Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899–910PubMedCrossRef
22.
Zurück zum Zitat Brandes DW, Shaya FT, Pill MW (2010) Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. Am J Manag Care 16:S171–S177PubMed Brandes DW, Shaya FT, Pill MW (2010) Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. Am J Manag Care 16:S171–S177PubMed
Metadaten
Titel
Screening for balance disorders in mildly affected multiple sclerosis patients
verfasst von
Malou H. J. Fanchamps
Henrik Gensicke
Jens Kuhle
Ludwig Kappos
John H. J. Allum
Özgür Yaldizli
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 7/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6366-5

Weitere Artikel der Ausgabe 7/2012

Journal of Neurology 7/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.